Analyzing An EU Medtech Regulation Crisis In The Making
Whose Fault Is It And Where Are The Solutions?
Executive Summary
EU medical device consultant Trevor Lewis takes note of the recent, if belated, progress towards the building of the post-MDR playing field for medical device companies in Europe, but calls political decision-makers and economic operators to account: getting it right is nothing short of a matter of life and death, he tells In Vivo.
You may also be interested in...
Device Week, 20 February 2020 – Industry Concerns Grow As Clock Is Running Out On EU MDR
With fewer than a hundred days left before the EU Medical Device Regulations kick in, Medtech Insight’s executive editor Ashley Yeo and managing editor Amanda Maxwell discuss in this week's podcast growing concerns by medtech industry members that they may not be ready in time to comply with the regulations and may inadvertently run afoul of them.
All About Value – Brexit Aside, UK Industry Sees Good Things Ahead For Healthtech Adoption
ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.
UK Medicines And Medical Devices Bill Laid Before Parliament
UK health minister Baroness Blackwood will introduce the new UK Medicines and Medical Devices Bill before Parliament today, just before the House of Commons goes into recess. The government wants new legislation for devices and medicines in place before the end of the Brexit transition period.
Need a specific report? 1000+ reports available
Buy Reports